These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 311698
1. Differential inhibition of adenosine deaminase deficient peripheral blood lymphocytes and lymphoid line cells by deoxyadenosine and adenosine. Hirschhorn R, Bajaj S, Borkowsky W, Kowalski A, Hong R, Rubinstein A, Papageorgiou P. Cell Immunol; 1979 Feb; 42(2):418-23. PubMed ID: 311698 [No Abstract] [Full Text] [Related]
2. Enzyme replacement and other biochemical approaches to the therapy of adenosine deaminase deficiency. Polmar SH. Ciba Found Symp; 1978 Feb; (68):213-30. PubMed ID: 227649 [Abstract] [Full Text] [Related]
3. A role for purine metabolism in the immune response: Adenosine-deaminase activity and deoxyadenosine catabolism. Simmonds HA, Panayi GS, Corrigall V. Lancet; 1978 Jan 14; 1(8055):60-3. PubMed ID: 74565 [Abstract] [Full Text] [Related]
4. Effects of deoxyadenosine on the activation of ADA inhibited T & B cells. Webster AD, Ip H, Pereira S. Clin Exp Immunol; 1982 Dec 14; 50(3):587-95. PubMed ID: 6299634 [Abstract] [Full Text] [Related]
5. The effect of adenosine on mitogenesis of ADA-deficient lymphocytes. Uberti J, Lightbody JJ, Wolf JW, Anderson JA, Reid RH, Johnson RM. Clin Immunol Immunopathol; 1978 Aug 14; 10(4):446-58. PubMed ID: 688701 [No Abstract] [Full Text] [Related]
8. The mechanism of inhibition and "reversal" of mitogen-induced lymphocyte activation in a model of adenosine deaminase deficiency. Albert D, Bluestein HG, Thompson L, Seegmiller JE. Cell Immunol; 1984 Jul 14; 86(2):510-7. PubMed ID: 6610485 [Abstract] [Full Text] [Related]
9. S-Adenosylhomocysteine hydrolase activity in a lymphoblastoid cell line from a patient with adenosine deaminase dificiency disease. Tsuchiya S, Nakae S, Konno T, Tada K. J Inherit Metab Dis; 1981 Jul 14; 4(4):197-201. PubMed ID: 6796770 [Abstract] [Full Text] [Related]
12. Deoxyadenosine metabolism and cytotoxicity in cultured mouse T lymphoma cells: a model for immunodeficiency disease. Ullman B, Gudas LJ, Cohen A, Martin DW. Cell; 1978 Jun 14; 14(2):365-75. PubMed ID: 208780 [No Abstract] [Full Text] [Related]
15. Metabolic basis for immune dysfunction in adenosine deaminase deficiency. Carson DA, Iizasa T, Seto S, Carrera CJ, Kubota M, Willis EH, Wasson DB, Kajander O. Ann N Y Acad Sci; 1985 Jun 14; 451():34-41. PubMed ID: 3878120 [No Abstract] [Full Text] [Related]
16. A phenotypically normal revertant of an adenosine deaminase-deficient lymphoblast cell line. Uberti J, Peterson WD, Lightbody JJ, Johnson RM. J Immunol; 1983 Jun 14; 130(6):2866-70. PubMed ID: 6854019 [Abstract] [Full Text] [Related]
19. Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s). Carson DA, Kaye J, Seegmiller JE. Proc Natl Acad Sci U S A; 1977 Dec 14; 74(12):5677-81. PubMed ID: 202960 [Abstract] [Full Text] [Related]